Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Limonene for Pulmonary Nodule Chemoprevention
NCT05525260Phase 2Recruiting
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Feb 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pulmonary nodules (SPN) comparing Limonene capsules with Placebo (2 arms). Primary endpoint: Changes in the sum of longest diameters of target nodules (multiple nodules) at 6 months. Started Feb 2023; status: recruiting.
02
Drugs
Limonene
03
Conditions
pulmonary nodules (SPN)
Beyond the preview
Go deeper on NCT05525260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05525260.